Novavax (NVAX) Other Non Operating Income (2010 - 2026)

Novavax's Other Non Operating Income history runs 15 years deep, the most recent figure standing at $11.8 million for Q1 2026.

• In Q1 2026, Other Non Operating Income rose 17.59% year-over-year to $11.8 million; the TTM figure through Mar 2026 stood at $102.3 million (up 75.6% YoY), while the FY2025 annual figure was $40.6 million, changed 0.47% from the prior year.
• Other Non Operating Income was $11.8 million for Q1 2026 at Novavax, down from $69.3 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $69.3 million in Q4 2025 to a low of -$34.8 million in Q3 2022.
• Historically, Other Non Operating Income has averaged $10.9 million across 5 years, with a median of $8.5 million in 2024.
• Biggest YoY gain for Other Non Operating Income was 14639.86% in 2022; the steepest drop was 756.31% in 2022.
• A 5-year view of Other Non Operating Income shows it stood at $64.0 million in 2022, then slumped by 142.07% to -$26.9 million in 2023, then jumped by 250.27% to $40.4 million in 2024, then jumped by 71.47% to $69.3 million in 2025, then tumbled by 82.95% to $11.8 million in 2026.
• The last three Other Non Operating Income figures came in at $11.8 million (Q1 2026), $69.3 million (Q4 2025), and $9.2 million (Q3 2025), per Business Quant data.